Omen AI
Omen AI Raises $31M Series A for Continuous Fluid Analysis Sensors
Omen AI announced $31M in Series A financing on June 30, 2026. Omen AI raised a $31 million Series A led by Nava Ventures, bringing total funding to $41.5 million; it makes continuous fluid analysis sensors for machines.
Round details
The financing includes backing from Nava Ventures, CRV, Sheryl Sandberg, Mike Mattacola, Vanderbilt University, LMNT Ventures, Mann+Hummel, Borusan Ventures. The company did not publish a valuation with the announcement.
- Round: Series A
- Capital announced: $31M
- Total funding reported: $41.5M
- Headquarters: San Francisco, CA
How the company plans to use the capital
The announcement did not state how the proceeds will be used. The release describes the company’s continuous fluid analysis sensors, a permanent monitoring sensor and a portable diagnostic unit, for data center and industrial equipment.
Why this matters for GTM teams
The release states that liquid cooling is becoming the default for new data center construction and describes the cooling fluid as an unmonitored point of failure as liquid-cooled infrastructure scales.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Omen AI Series A announcement.
Company Info
Investors (8)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


